Doctors investigate if common painkiller changes blood thinner effectiveness in cancer patients
NCT ID NCT07384013
Summary
This study aims to understand how a pain medication called metamizole (Optalgin) affects the blood levels of certain blood thinners (DOACs) in cancer patients. Researchers will measure blood thinner concentrations in 30 adult cancer patients who take both medications. The goal is to gather information about potential drug interactions to help guide safer medication use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rambam Health Care Campus
RECRUITINGHaifa, 31096, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.